Annual report pursuant to Section 13 and 15(d)

Summary of Stock Options Activity (Details)

v3.22.1
Summary of Stock Options Activity (Details) - USD ($)
 12 Months Ended
Dec. 09, 2021
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]    
Number of Shares, Beginning Balance   4,188,315
Weighted Average Exercise Price, Beginning Balance   $ 2.59
Weighted Average Grant Date Fair Value, Beginning   $ 2.59
Weighted Average Remaining Contractual Term (Years), Beginning   2 years 4 months 13 days
Aggregate Intrinsic Value, Beginning Balance   $ 5,805,667
Number of Shares, Granted  
Weighted Average Exercise Price, Granted  
Weighted Average Grant Date Fair Value, Granted  
Number of Shares, Exercised (11,576) (11,576)
Weighted Average Exercise Price, Exercised   $ 2.59
Weighted Average Grant Date Fair Value, Exercised   $ 2.59
Weighted Average Remaining Contractual Term (Years), Exercised   1 year 3 months 14 days
Number of Shares, Forfeited  
Weighted Average Exercise Price, Forfeited  
Weighted Average Grant Date Fair Value, Forfeited  
Number of Shares, Canceled/Expired  
Weighted Average Exercise Price, Canceled/Expired  
Weighted Average Grant Date Fair Value, Canceled/Expired  
Number of Shares, Ending Balance   4,176,739
Weighted Average Exercise Price, Ending Balance $ 2.59 $ 2.59
Weighted Average Grant Date Fair Value, Ending   $ 2.59
Weighted Average Remaining Contractual Term (Years), Ending   1 year 3 months 14 days
Aggregate Intrinsic Value, Ending Balance   $ 14,493,284
Number of Shares, Exercisable   4,176,739
Weighted Average Exercise Price, Exercisable   $ 2.59
Weighted Average Grant Date Fair Value, Exercisable   $ 2.59
Weighted Average Remaining Contractual Term (Years), Exercisable   1 year 3 months 14 days
Aggregate Intrinsic Value, Exercisable   $ 14,493,284